18.05
Arcturus Therapeutics Holdings Inc stock is traded at $18.05, with a volume of 581.91K.
It is down -0.22% in the last 24 hours and down -7.34% over the past month.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
See More
Previous Close:
$18.09
Open:
$18.03
24h Volume:
581.91K
Relative Volume:
1.07
Market Cap:
$490.14M
Revenue:
$157.75M
Net Income/Loss:
$-29.73M
P/E Ratio:
-15.56
EPS:
-1.16
Net Cash Flow:
$-21.00M
1W Performance:
+0.33%
1M Performance:
-7.34%
6M Performance:
+27.47%
1Y Performance:
-14.09%
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
Name
Arcturus Therapeutics Holdings Inc
Sector
Industry
Phone
(858) 900-2660
Address
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Compare ARCT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ARCT
Arcturus Therapeutics Holdings Inc
|
18.05 | 491.23M | 157.75M | -29.73M | -21.00M | -1.16 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-04-25 | Resumed | H.C. Wainwright | Buy |
May-28-25 | Initiated | Scotiabank | Sector Outperform |
Jan-28-25 | Initiated | BTIG Research | Buy |
Aug-12-24 | Initiated | Leerink Partners | Outperform |
Dec-13-23 | Initiated | Canaccord Genuity | Buy |
Jul-24-23 | Initiated | William Blair | Outperform |
May-11-23 | Upgrade | H.C. Wainwright | Neutral → Buy |
Nov-14-22 | Resumed | Wells Fargo | Overweight |
Nov-10-22 | Downgrade | Robert W. Baird | Neutral → Underperform |
Nov-03-22 | Upgrade | Citigroup | Neutral → Buy |
Nov-02-22 | Upgrade | Barclays | Underweight → Equal Weight |
Aug-10-22 | Downgrade | Raymond James | Mkt Perform → Underperform |
Jul-19-22 | Resumed | Cantor Fitzgerald | Overweight |
May-11-22 | Upgrade | Robert W. Baird | Underperform → Neutral |
Apr-21-22 | Downgrade | Citigroup | Buy → Neutral |
Jan-31-22 | Upgrade | Raymond James | Underperform → Mkt Perform |
Aug-12-21 | Downgrade | Raymond James | Mkt Perform → Underperform |
Aug-11-21 | Downgrade | Goldman | Neutral → Sell |
Aug-10-21 | Downgrade | Robert W. Baird | Neutral → Underperform |
Jul-02-21 | Initiated | Cantor Fitzgerald | Overweight |
Jun-25-21 | Resumed | Goldman | Neutral |
Jun-21-21 | Downgrade | Barclays | Equal Weight → Underweight |
Jun-04-21 | Resumed | Robert W. Baird | Neutral |
Feb-17-21 | Downgrade | B. Riley Securities | Neutral → Sell |
Jan-19-21 | Downgrade | B. Riley Securities | Buy → Neutral |
Jan-15-21 | Downgrade | B. Riley Securities | Buy → Neutral |
Jan-07-21 | Initiated | Wells Fargo | Overweight |
Dec-29-20 | Downgrade | Barclays | Overweight → Equal Weight |
Dec-29-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
Dec-29-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
Dec-29-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
Dec-23-20 | Downgrade | ROTH Capital | Buy → Sell |
Dec-08-20 | Reiterated | B. Riley Securities | Buy |
Dec-07-20 | Reiterated | B. Riley Securities | Buy |
Oct-26-20 | Initiated | Barclays | Overweight |
Oct-06-20 | Initiated | Citigroup | Buy |
Aug-26-20 | Initiated | Piper Sandler | Overweight |
Jul-30-20 | Resumed | ROTH Capital | Buy |
Jul-16-20 | Initiated | Raymond James | Outperform |
Jul-13-20 | Initiated | B. Riley FBR | Buy |
Jun-09-20 | Downgrade | WBB Securities | Buy → Hold |
Feb-11-20 | Initiated | Robert W. Baird | Outperform |
Feb-07-20 | Initiated | Guggenheim | Buy |
Feb-06-20 | Initiated | Guggenheim | Buy |
Apr-05-19 | Initiated | H.C. Wainwright | Buy |
Sep-20-18 | Upgrade | WBB Securities | Buy → Strong Buy |
Jan-22-18 | Initiated | Chardan Capital Markets | Buy |
View All
Arcturus Therapeutics Holdings Inc Stock (ARCT) Latest News
Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate - MSN
Dynamic Technology Lab Private Ltd Invests $299,000 in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Arcturus Therapeutics (NASDAQ:ARCT) Shares Up 5.4%Here's Why - MarketBeat
Highs Report: Is Arcturus Therapeutics Holdings Inc backed by strong institutional buying2025 Dividend Review & Free Reliable Trade Execution Plans - خودرو بانک
Goldman Sachs Group Inc. Acquires 42,636 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Risk Analysis: What’s the beta of Arcturus Therapeutics Holdings Inc. stockGDP Growth & AI Based Buy/Sell Signal Reports - خودرو بانک
Arcturus Therapeutics Holdings Inc. $ARCT Shares Sold by Woodline Partners LP - MarketBeat
Shorts Report: How is Arcturus Therapeutics Holdings Inc managing supply chain issuesEarnings Beat & Capital Protection Trading Alerts - خودرو بانک
Analyst Calls: Can Arcturus Therapeutics Holdings Inc sustain its profitability2025 Market Sentiment & Technical Pattern Based Signals - خودرو بانک
Decliners Report: Is Arcturus Therapeutics Holdings Inc. vulnerable to short sellersPortfolio Update Summary & Stock Timing and Entry Methods - خودرو بانک
Inflation Data: Can Arcturus Therapeutics Holdings Inc sustain its profitabilityWeekly Trend Summary & AI Enhanced Trading Signals - خودرو بانک
US Stocks Recap: Is Arcturus Therapeutics Holdings Inc. affected by consumer sentimentJuly 2025 Market Mood & Growth Focused Entry Reports - خودرو بانک
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth - The Globe and Mail
Will Arcturus Therapeutics Holdings Inc. benefit from macro trendsJuly 2025 Fed Impact & High Accuracy Investment Signals - newser.com
Applying Elliott Wave Theory to Arcturus Therapeutics Holdings Inc.July 2025 Opening Moves & Fast Gaining Stock Reports - newser.com
Applying big data sentiment scoring on Arcturus Therapeutics Holdings Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
Visualizing Arcturus Therapeutics Holdings Inc. stock with heatmaps2025 Year in Review & Stepwise Trade Signal Guides - newser.com
Arcturus Therapeutics Holdings Inc. stock prediction for this weekIndex Update & Free Community Supported Trade Ideas - newser.com
Will Arcturus Therapeutics Holdings Inc. stock recover after recent dropJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
Jacobs Levy Equity Management Inc. Has $1.53 Million Stake in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
What is HC Wainwright's Estimate for ARCT Q3 Earnings? - MarketBeat
Invesco Ltd. Acquires 15,836 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Arcturus Therapeutics (NASDAQ:ARCT) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Will Arcturus Therapeutics Holdings Inc. benefit from rate cuts2025 Price Momentum & Capital Efficient Trade Techniques - beatles.ru
Vestal Point Capital LP Acquires New Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Real time alert setup for Arcturus Therapeutics Holdings Inc. performanceWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Is Arcturus Therapeutics Holdings Inc. backed by strong institutional buyingJuly 2025 PreEarnings & Weekly Top Stock Performers List - خودرو بانک
American Century Companies Inc. Increases Stock Position in Arcturus Therapeutics Holdings Inc. $ARCT - Defense World
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Rating of "Buy" by Analysts - MarketBeat
Applying sector rotation models to Arcturus Therapeutics Holdings Inc.Dollar Strength & Low Drawdown Momentum Ideas - Newser
Automated trading signals detected on Arcturus Therapeutics Holdings Inc. - Newser
What’s the beta of Arcturus Therapeutics Holdings Inc. stock2025 Volume Leaders & Weekly Watchlist of Top Performers - خودرو بانک
Is Arcturus Therapeutics Holdings Inc. stock undervalued right nowJuly 2025 Sector Moves & Verified Chart Pattern Trade Signals - خودرو بانک
Does Arcturus Therapeutics Holdings Inc. qualify in momentum factor screeningEarnings Recap Summary & Smart Money Movement Alerts - Newser
Arcturus Therapeutics Holdings Inc. recovery potential after sell offMarket Activity Recap & Precise Entry and Exit Recommendations - Newser
What Fibonacci levels say about Arcturus Therapeutics Holdings Inc. reboundEarnings Overview Report & Reliable Intraday Trade Plans - Newser
Live market analysis of Arcturus Therapeutics Holdings Inc.July 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Multi factor analysis applied to Arcturus Therapeutics Holdings Inc.Dip Buying & Long-Term Growth Stock Strategies - Newser
Tools to monitor Arcturus Therapeutics Holdings Inc. recovery probabilityMarket Trend Review & High Conviction Buy Zone Picks - Newser
Relative strength of Arcturus Therapeutics Holdings Inc. in sector analysis2025 Support & Resistance & Weekly Momentum Picks - Newser
Can you recover from losses in Arcturus Therapeutics Holdings Inc.Gap Down & Daily Risk Controlled Trade Plans - Newser
Is Arcturus Therapeutics Holdings Inc. forming a reversal patternQuarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - Newser
Vanguard Group Inc. Increases Stock Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Is a relief rally coming for Arcturus Therapeutics Holdings Inc. holdersDividend Hike & Weekly Momentum Picks - Newser
Volume spikes in Arcturus Therapeutics Holdings Inc. stock – what they meanNew Guidance & Verified Trade Idea Suggestions - Newser
Visual trend scoring systems applied to Arcturus Therapeutics Holdings Inc.2025 Year in Review & Free Expert Verified Stock Movement Alerts - Newser
How institutional ownership impacts Arcturus Therapeutics Holdings Inc. stockRecession Risk & Low Risk Entry Point Tips - Newser
Is Arcturus Therapeutics Holdings Inc. vulnerable to short sellersEarnings Risk Summary & Stepwise Trade Signal Guides - خودرو بانک
Top chart patterns to watch in Arcturus Therapeutics Holdings Inc.July 2025 Update & Free Long-Term Investment Growth Plans - Newser
When is the best time to exit Arcturus Therapeutics Holdings Inc.Forecast Cut & AI Based Buy and Sell Signals - Newser
Signal strength of Arcturus Therapeutics Holdings Inc. stock in tech scannersJuly 2025 Spike Watch & Capital Protection Trading Alerts - Newser
Arcturus Therapeutics Holdings Inc Stock (ARCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):